JP2001164030A - Porous membrane and production thereof - Google Patents

Porous membrane and production thereof

Info

Publication number
JP2001164030A
JP2001164030A JP35231799A JP35231799A JP2001164030A JP 2001164030 A JP2001164030 A JP 2001164030A JP 35231799 A JP35231799 A JP 35231799A JP 35231799 A JP35231799 A JP 35231799A JP 2001164030 A JP2001164030 A JP 2001164030A
Authority
JP
Japan
Prior art keywords
component
porous membrane
film
membrane
anisotropic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP35231799A
Other languages
Japanese (ja)
Inventor
Ken Takebe
建 建部
Katsuyuki Oba
克行 大場
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP35231799A priority Critical patent/JP2001164030A/en
Publication of JP2001164030A publication Critical patent/JP2001164030A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a porous membrane that can rapidly be shortened the time required for developing specimens, for example, blood and can be used as a test paper for determination of specific components in the specimens, for example, blood sugar or the like with markedly high measurement accuracy. SOLUTION: This objective anisotropic porous membrane is obtained by wet-extruding a membrane dope including the first water-insoluble polymer as the membrane component and the second water-soluble and extractable components in which the concentration of the first component polymer is in the range of 12-15 wt.%.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明が属する技術分野】本発明は、例えば血糖値の測
定のような、検体中の目的成分の量を測定する多孔質
膜、その製造方法、及びその多孔質膜を用いた試験紙に
関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a porous membrane for measuring the amount of a target component in a specimen, for example, for measuring a blood glucose level, a method for producing the same, and a test paper using the porous membrane. It is.

【0002】[0002]

【従来の技術】血糖値の測定を行う血糖測定装置(血中
成分測定装置)が知られている。この血糖測定装置は、
血中のブドウ糖量に応じて呈色する試験紙の呈色の度合
いを光学的に測定(測色)して血糖値を定量化するもの
である。このような従来の血糖測定装置では、試験紙の
測色は、発光素子および受光素子を備える測光部におい
て、試験紙に光を照射しその反射光の強度を測定するこ
とにより行われている。この血糖測定装置では、試験紙
に血液(検体)を供給・展開する操作を行った後、その
試験紙を遮光状態が確保される空間へ挿入し、血糖値の
測定を開始するが、操作性が劣るという欠点があるとと
もに、試験紙への血液の供給から測色までの時間が一定
でなく、それによる測定誤差が生じるという問題があ
る。そのため、試験紙への供給・展開から測定までの一
連の操作を連続的、自動的に行うことが出来る血糖自動
測定装置の開発が望まれている。
2. Description of the Related Art A blood glucose measuring device (blood component measuring device) for measuring a blood glucose level is known. This blood glucose measurement device
The blood glucose level is quantified by optically measuring (colorimetrically measuring) the degree of coloration of the test paper that is colored according to the amount of glucose in the blood. In such a conventional blood glucose measuring device, the colorimetry of the test paper is performed by irradiating the test paper with light and measuring the intensity of the reflected light in a photometric unit having a light emitting element and a light receiving element. In this blood glucose measuring device, after performing an operation of supplying and developing blood (specimen) on a test paper, the test paper is inserted into a space where light shielding is ensured, and measurement of a blood glucose level is started. In addition, there is a problem that the time from the supply of blood to the test paper to the color measurement is not constant, resulting in a measurement error. Therefore, development of an automatic blood glucose measuring device capable of continuously and automatically performing a series of operations from supply / deployment to test paper to measurement is desired.

【0003】また、従来の試験紙は、検体を吸収可能な
多孔質材料で構成された1枚のシート基材に試薬を担持
させた構成のものである。この試験紙では、シート基材
の細孔の孔径が0.5μm程度と小さいため、通水性、
すなわち展延性が低く、そのため検体の展開に時間がか
かるという問題がある。このように検体の展開に要する
時間が長いということは、とくに、前記血糖自動測定装
置にとって不利である。
Further, the conventional test paper has a structure in which a reagent is carried on one sheet substrate made of a porous material capable of absorbing a specimen. In this test paper, since the pore diameter of the pores of the sheet substrate is as small as about 0.5 μm, water permeability,
That is, there is a problem that the spreadability is low, and it takes time to develop the specimen. Such a long time required for the development of the sample is particularly disadvantageous for the automatic blood glucose measuring device.

【0004】また、このような問題点を解決する手段と
して、(1)検体中の特定成分と反応して呈色する試薬
を担持する多孔質の第1の層と、検体中の濾別物を濾別
する機能を有する多孔質の第2の層とを積層してなり、
前記第1の層側から検体を供給して使用することを特徴
とする試験紙、(2)前記第1の層および前記第2の層
がそれぞれ親水性を有している上記(1)に記載の試験
紙、(3)前記第1の層における細孔の孔径が8〜50
μmである上記(1)または(2)に記載の試験紙、
(4)前記第2の層における細孔の孔径が5μm 以下
である上記(1)ないし(3)のいずれかに記載の試験
紙、及び(5)前記検体は血液であり、前記濾別物は主
に赤血球を含む血球である上記(1)ないし(4)のい
ずれかに記載の試験紙が、特開平11−183474号
で示されている。
[0004] As means for solving such problems, (1) a porous first layer carrying a reagent which reacts with a specific component in a sample to produce a color, and a filter separated in the sample are separated. Laminated with a porous second layer having a function of filtering,
(2) The test paper according to (1), wherein the specimen is supplied and used from the first layer side, and (2) the first layer and the second layer each have hydrophilicity. (3) The pore size of the pores in the first layer is from 8 to 50.
the test paper according to the above (1) or (2),
(4) The test paper according to any one of (1) to (3), wherein the pore diameter of the pores in the second layer is 5 μm or less, and (5) the specimen is blood, and the separated substance is blood. The test paper according to any one of the above (1) to (4), which is a blood cell mainly containing red blood cells, is disclosed in JP-A-11-183474.

【0005】以上のような第1の層と第2の層に分かれ
た試験紙を使用することで、前述の問題が解決されると
いう。しかしながらこのような試験紙を用いた場合に
も、以下のような問題点がある。第2層目の多孔質膜
は、血球を濾別しつつ試薬と反応した血漿成分を迅速に
測定面へ展開させうることが要求される。血球を濾別・
除去するためには孔径を小さくする程効果があるが、孔
径を小さくしすぎると血漿成分の展開が遅くなる。ま
た、入り口側の孔径を大きくし、出口側の孔径を小さく
することで展開速度を維持しつつ血球を除去する方法も
あるが、血球除去が測定面直前で行われたのでは、血球
成分の血色素が多孔質構造を通して透けて見えてしま
い、測定精度に影響してしまう。
[0005] It is said that the above-mentioned problem is solved by using the test paper divided into the first layer and the second layer as described above. However, the use of such a test paper also has the following problems. The second porous membrane is required to be able to rapidly spread the plasma component reacted with the reagent to the measurement surface while filtering the blood cells. Filter blood cells
The effect is smaller as the pore size is reduced for removal, but if the pore size is too small, the development of the plasma component is slowed down. There is also a method of removing blood cells while maintaining the expansion speed by increasing the hole diameter on the entrance side and reducing the hole diameter on the exit side.However, if blood cell removal was performed immediately before the measurement surface, blood cell components The hemoglobin is seen through the porous structure, which affects the measurement accuracy.

【0006】[0006]

【発明が解決しようとする課題】本発明の目的は、検体
の展開に要する時間を飛躍的に短縮することができ、か
つ非常に測定精度が高い、検体中の特定成分測定用試験
紙、それに用いる多孔質膜、及び多孔質膜の製造方法を
提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a test paper for measuring a specific component in a sample, which can drastically reduce the time required for developing the sample and which has extremely high measurement accuracy. An object of the present invention is to provide a porous film to be used and a method for producing the porous film.

【0007】[0007]

【課題を解決するための手段】このような目的は、下記
の本発明により達成される。 (1)本発明は、平均孔径が0.1〜2μm、膜厚が5
0〜200μm及び空孔率が50〜95%の多孔質膜で
あり、一方の表面の平均孔径と他方の表面の平均孔径の
比が1.5以上である異方性の多孔質膜である。 (2)本発明は、赤血球が透過しない上記(1)に記載
の異方性の多孔質膜である。
This and other objects are achieved by the present invention described below. (1) In the present invention, the average pore diameter is 0.1 to 2 μm and the film thickness is 5
A porous membrane having a pore size of 0 to 200 μm and a porosity of 50 to 95%, and a ratio of the average pore diameter on one surface to the average pore diameter on the other surface being 1.5 or more. . (2) The present invention is the anisotropic porous membrane according to the above (1), through which red blood cells do not pass.

【0008】(3)本発明は、膜成分となる非水溶性第
1成分ポリマーと被抽出成分である水溶性第2成分を含
み、第1成分ポリマーの濃度が12〜15wt%の製膜
原液を湿式製膜することによって得られる異方性の多孔
質膜である。 (4)本発明は、平均孔径が0.1〜2μm、膜厚が5
0〜200μm及び空孔率が50〜95%の多孔質膜で
あり、一方の表面の平均孔径と他方の表面の平均孔径の
比が1.5以上である上記(3)に記載の異方性の多孔
質膜である。
(3) The present invention provides a stock solution containing a water-insoluble first component polymer as a membrane component and a water-soluble second component to be extracted, wherein the concentration of the first component polymer is 12 to 15% by weight. Is an anisotropic porous film obtained by wet film-forming. (4) In the present invention, the average pore diameter is 0.1 to 2 μm and the film thickness is 5
The anisotropic described in (3) above, wherein the porous membrane has a pore size of 0 to 200 μm and a porosity of 50 to 95%, and the ratio of the average pore size on one surface to the average pore size on the other surface is 1.5 or more. Porous membrane.

【0009】(5)本発明は、赤血球が透過しない上記
(3)乃至(4)に記載の異方性の多孔質膜である。 (6)本発明は、前記製膜原液の前記第1成分ポリマー
と前記第2成分との仕込み比が3:1〜1.5:1であ
る上記(3)乃至(5)に記載の異方性の多孔質膜であ
る。
(5) The present invention is the anisotropic porous membrane according to the above (3) or (4), through which red blood cells do not pass. (6) The invention according to (3) to (5), wherein the charge ratio of the first component polymer and the second component of the stock solution is 3: 1 to 1.5: 1. It is an isotropic porous membrane.

【0010】(7)本発明は、60〜80w/w%の前記
製膜原液の溶媒を含む水系凝固浴を行い湿式製膜するこ
とによって得られる上記(3)乃至(6)に記載の異方
性の多孔質膜である。 (8)本発明は、前記第1成分ポリマーがポリエーテル
スルホンである上記(3)乃至(7)に記載の異方性の
多孔質膜である。
(7) The present invention provides the method according to (3) to (6), which is obtained by performing an aqueous coagulation bath containing a solvent for the film forming stock solution at 60 to 80 w / w% to perform wet film formation. It is an isotropic porous membrane. (8) The present invention is the anisotropic porous membrane according to the above (3) to (7), wherein the first component polymer is polyether sulfone.

【0011】(9)本発明は、前記第2成分がポリビニ
ルピロリドンである上記(3)乃至(7)に記載の異方
性の多孔質膜である。 (10)本発明は、上記(1)乃至(9)に記載の多孔
質膜の平均孔径の小さい面に、他の多孔質膜を積層する
ことによって得られる試験紙である。
(9) The present invention is the anisotropic porous membrane according to the above (3) to (7), wherein the second component is polyvinylpyrrolidone. (10) The present invention is a test paper obtained by laminating another porous membrane on the surface having a small average pore diameter of the porous membrane according to the above (1) to (9).

【0012】(11)本発明は、膜成分となる非水溶性
第1成分ポリマーと被抽出成分である水溶性第2成分を
含み、第1成分ポリマーの濃度が12〜15wt%の製
膜原液を用いて湿式製膜することを特徴とする異方性の
多孔質膜の製造方法である。 (12)本発明は、前記第1成分ポリマーと前記第2成
分との仕込み比が3:1〜1.5:1の製膜原液を用い
ることを特徴とする上記(11)に記載の異方性の多孔
質膜の製造方法である。
(11) The present invention provides a stock solution containing a water-insoluble first component polymer as a membrane component and a water-soluble second component as a component to be extracted, wherein the concentration of the first component polymer is 12 to 15% by weight. This is a method for producing an anisotropic porous film, characterized in that a wet film is formed by using the method. (12) The method according to the above (11), wherein the stock ratio of the first component polymer to the second component is 3: 1 to 1.5: 1. This is a method for producing an isotropic porous membrane.

【0013】(13)本発明は、60〜80w/w%の前
記製膜原液の溶媒を含む水系凝固浴を行い湿式製膜する
ことを特徴とする上記(11)乃至(12)に記載の異
方性の多孔質膜の製造方法である。 (14)本発明は、前記第1成分ポリマーがポリエーテ
ルスルホンであることを特徴とするを特徴とする上記
(11)乃至(13)に記載の異方性の多孔質膜の製造
方法である。 (13)本発明は、前記第2成分がポリビニルピロリド
ンであることを特徴とする上記(11)乃至(13)に
記載の異方性の多孔質膜の製造方法である。
(13) The invention according to (11) to (12), wherein the wet film formation is performed by performing an aqueous coagulation bath containing a solvent of the film forming stock solution at 60 to 80 w / w%. This is a method for producing an anisotropic porous membrane. (14) The present invention is the method for producing an anisotropic porous membrane according to any one of (11) to (13), wherein the first component polymer is polyether sulfone. . (13) The present invention is the method for producing an anisotropic porous membrane according to any one of (11) to (13), wherein the second component is polyvinylpyrrolidone.

【0014】[0014]

【発明の実施の形態】本発明の異方性の多孔質膜は、一
方の表面の平均孔径が他方の表面の平均孔径よりも小さ
いものであり、一方の表面から特定成分を含む検体を供
給し、他方の表面から光学的方法などにより特定成分の
測定を行うものである。そのため、血球などの浮遊物を
濾別し、試薬と反応した血漿成分などの特定成分を迅速
に一方の表面から他方の表面へ展開させることが必要と
される。血球などの浮遊物を濾別・除去するためには、
孔径を小さくすることで解決できるが、孔径を小さくし
すぎると血漿成分などの特定成分の展開が遅くなってし
まう。また、試薬と反応した血漿成分などの特定成分を
供給する側の孔径を大きくし、他方の孔径を小さくする
ことで展開速度を維持しつつ血球などの浮遊物を除去す
る方法もあるが、浮遊物の濾別・除去が測定する表面の
近くで行われるため、血球成分の血色素が多孔質構造を
通して透けて見えてしまい測定の精度に影響を及ぼして
しまう。
BEST MODE FOR CARRYING OUT THE INVENTION The anisotropic porous membrane of the present invention has an average pore size on one surface smaller than the average pore size on the other surface, and supplies a sample containing a specific component from one surface. Then, a specific component is measured from the other surface by an optical method or the like. Therefore, it is necessary to separate suspended components such as blood cells by filtration and to rapidly spread a specific component such as a plasma component reacted with a reagent from one surface to the other surface. To filter and remove suspended matter such as blood cells,
The problem can be solved by reducing the pore size, but if the pore size is too small, the development of a specific component such as a plasma component is delayed. In addition, there is a method of removing floating substances such as blood cells while maintaining the developing speed by increasing the pore size on the side for supplying a specific component such as a plasma component reacted with the reagent and reducing the other pore size. Since the filtration / removal of the object is performed near the surface to be measured, the blood pigment of the blood cell component is seen through the porous structure, which affects the accuracy of the measurement.

【0015】そこで、特定成分を含む検体供給する側の
表面の孔径を小さくし、他方の孔径を大きくする異方性
構造とすることで、血球などの浮遊物を濾別・除去を的
確に行うとともに、血漿成分などの特定成分の測定する
側の表面への展開速度、測定精度を向上させることが可
能となる。
[0015] Therefore, by making the pore size of the surface on the sample supply side containing the specific component smaller and increasing the other pore size, the suspended matter such as blood cells can be accurately filtered and removed. At the same time, it is possible to improve the development speed and measurement accuracy of a specific component such as a plasma component on the surface on the side to be measured.

【0016】本発明の異方性の多孔質膜の具体的な構造
として、平均孔径は0.1〜2μm、望ましくは0.3〜
1.6μm、より望ましくは0.5〜1.3μmであり、
検体中の特定成分を測定する側の表面の平均孔径と他方
の表面の平均孔径との比は1.5以上、望ましくは2.0
以上、より望ましくは2.3以上である。
As a specific structure of the anisotropic porous membrane of the present invention, the average pore size is 0.1 to 2 μm, preferably 0.3 to 2 μm.
1.6 μm, more preferably 0.5 to 1.3 μm,
The ratio of the average pore size of the surface on the side where the specific component in the sample is measured to the average pore size of the other surface is 1.5 or more, preferably 2.0.
As described above, it is more preferably 2.3 or more.

【0017】本発明の異方性の多孔質膜の膜厚は、特に
限定しないが50〜200μm、望ましくは70〜18
0μm、より望ましくは80〜150μmである。膜厚
が50μmを下回ると、膜強度が不足してしまい、20
0μmを越えてしまうと検体の展開に時間がかかってし
まうためである。
The thickness of the anisotropic porous film of the present invention is not particularly limited, but is 50 to 200 μm, preferably 70 to 18 μm.
0 μm, more preferably 80 to 150 μm. If the film thickness is less than 50 μm, the film strength becomes insufficient, and
If the thickness exceeds 0 μm, it takes time to develop the specimen.

【0018】本発明の異方性の多孔質膜の空孔率は、特
に限定しないが50〜95%、望ましくは70〜90
%、より望ましくは75〜85%である。空孔率が50
%を下回ると必要な量の検体を吸収展開することが出来
なくなり、95%を越えると膜強度が不足してしまうた
めである。
Although the porosity of the anisotropic porous membrane of the present invention is not particularly limited, it is 50 to 95%, preferably 70 to 90%.
%, More preferably 75 to 85%. Porosity of 50
If it is less than 95%, it becomes impossible to absorb and develop a required amount of the sample, and if it exceeds 95%, the membrane strength becomes insufficient.

【0019】本発明の異方性の多孔質膜の膜材質となる
ポリマーとしては、ニトロセルロース、ポリビニルジフ
ロライド、セルロースアセテート、ポリスルホン、ポリ
エーテルスルホン、ポリエチレンなどが使用できるが、
とりわけ血糖値を測定するために使用する試薬を担持し
た場合には、ポリエーテルスルホンが試薬活性の経時的
劣化が最も少なく好適に使用できる。
As the polymer used as the film material of the anisotropic porous membrane of the present invention, nitrocellulose, polyvinyl difluoride, cellulose acetate, polysulfone, polyether sulfone, polyethylene and the like can be used.
In particular, when a reagent used for measuring a blood glucose level is supported, polyether sulfone can be suitably used with the least deterioration of the reagent activity with time.

【0020】本発明の異方性の多孔質膜の製造方法とし
ては、湿式製膜が望ましい方法である。多孔質膜の製造
方法としては、他にも溶融製膜、乾式製膜なども知られ
ているが、一方の表面の孔径が反対側の表面の孔径と異
なる異方性膜を製造するには湿式製膜が望ましい方法で
ある。本発明の製造方法は、製膜原液を膜状に広げ水系
凝固浴を行い乾燥させることによって行われる。
As a method for producing the anisotropic porous film of the present invention, wet film formation is a preferable method. As a method for producing a porous film, there are also known a melt film formation, a dry film formation, and the like.However, in order to produce an anisotropic film in which the pore size of one surface is different from the pore size of the opposite surface. Wet film formation is the preferred method. The production method of the present invention is carried out by spreading a film-forming stock solution in a film form, performing an aqueous coagulation bath and drying.

【0021】製膜原液を膜状に広げる工程は、ガラスな
どの基材の表面に製膜原液を押し広げあるいは塗り広げ
ることなどにより行われる。この方法は、最終的に得ら
れる多孔質膜の異方性を高め、多孔質膜の一方の表面
(空気に接する面)の孔径と他方の表面(基材に接する
面)の孔径の比を1.5以上に保つのに有効である。
The step of spreading the film-forming stock solution into a film is performed by, for example, spreading or spreading the film-forming stock solution on the surface of a substrate such as glass. This method increases the anisotropy of the finally obtained porous membrane and increases the ratio of the pore diameter of one surface (surface in contact with air) to the pore size of the other surface (surface in contact with the base material). It is effective to keep it at 1.5 or more.

【0022】本発明に用いる製膜原液は、膜成分となる
非水溶性第1成分ポリマーと被抽出成分である水溶性第
2成分を含み、第1成分ポリマーの濃度が12〜15w
t%のものが望ましい。本発明の多孔質膜は、平均孔径
が0.1〜2μmの範囲が好適である。そのため第1成
分ポリマー濃度が15wt%を越えてしまっては孔径が
小さくなってしまい、12wt%を下回ったのでは孔径
が大きくなりすぎてしまう。また、第1成分ポリマーの
みの単一のポリマー溶液から製造した場合、そのポリマ
ーの凝集力により緻密な構造となってしまうが、被抽出
成分である水溶性第2成分を製膜原液に添加すること
で、ポリマーの凝集を抑制し、また該成分を抽出除去し
たあとの空間に孔が形成され空孔率を向上させることが
出来る。
The stock solution used in the present invention contains a water-insoluble first component polymer as a membrane component and a water-soluble second component as a component to be extracted, and the concentration of the first component polymer is 12 to 15 watts.
t% is desirable. The average pore diameter of the porous membrane of the present invention is preferably in the range of 0.1 to 2 μm. Therefore, if the concentration of the first component polymer exceeds 15 wt%, the pore diameter becomes small, and if it is less than 12 wt%, the pore diameter becomes too large. Further, when the polymer is produced from a single polymer solution containing only the first component polymer, the polymer has a dense structure due to the cohesive force of the polymer. However, the water-soluble second component, which is the component to be extracted, is added to the stock solution. Thereby, aggregation of the polymer is suppressed, and pores are formed in the space after the components are extracted and removed, so that the porosity can be improved.

【0023】第1成分ポリマーとしては、ニトロセルロ
ース、ポリフッ化ビニリデン、セルロースアセテート、
ポリスルホン、ポリエチレンなどが使用できるが、最終
的に得られる多孔質膜がとりわけ血糖値を測定するため
に使用する試薬を担持する場合には、ポリエーテルスル
ホンが試薬の経時劣化が最も少なく好適に使用できる。
被抽出成分である水溶性第2成分としては、第1成分ポ
リマーと完全に溶解せず、溶媒には溶解し、凝固後に容
易に抽出除去できるポリビニルピロリドン、ポリエチレ
ングリコール、ポリアクリルアミド、ポリアクリル酸、
ヒドロキシプロピルセルロース、メチルセルロースなど
があげられる。特にポリビニルピロリドンはニトロセル
ロース、ポリビニルジフロライド、セルロースアセテー
ト、ポリスルホン、ポリエチレン、ポリエーテルスルホ
ンなどとは溶解せず、これらのポリマーを溶かす極性溶
媒に溶解し、凝固後には水により抽出除去できるといっ
た特性を持つため望ましい。さらに、ポリビニルピロリ
ドンは抽出後も微量であるが最終的に得られる多孔質膜
に残存し、その水親和性から多孔質膜の親水性を確保す
る効果も有する。
As the first component polymer, nitrocellulose, polyvinylidene fluoride, cellulose acetate,
Polysulfone, polyethylene, etc. can be used, but when the finally obtained porous membrane supports a reagent used for measuring blood glucose level, polyether sulfone is preferably used since the reagent has the least deterioration over time. it can.
As the water-soluble second component to be extracted, polyvinylpyrrolidone, polyethylene glycol, polyacrylamide, polyacrylic acid, which does not completely dissolve in the first component polymer but dissolves in the solvent and can be easily extracted and removed after coagulation,
Examples include hydroxypropyl cellulose and methyl cellulose. In particular, polyvinylpyrrolidone does not dissolve in nitrocellulose, polyvinyl difluoride, cellulose acetate, polysulfone, polyethylene, polyethersulfone, etc., but dissolves in a polar solvent that dissolves these polymers, and can be extracted and removed with water after coagulation. It is desirable to have In addition, polyvinylpyrrolidone is present in a small amount even after extraction but remains in the finally obtained porous membrane, and has an effect of securing the hydrophilicity of the porous membrane from its water affinity.

【0024】第1成分ポリマーと水溶性第2成分の溶解
を目的とする製膜原液の溶媒としては、具体的には、N
−メチル−2−ピロリドン、ジメチルホルムアミド、ジ
メチルスルホキシド、ジメチルアセトアミドなどの有機
極性溶媒などがあげられるが、特に望ましいのはN−メ
チル−2−ピロリドンである。
The solvent of the stock solution for the purpose of dissolving the first component polymer and the water-soluble second component is, specifically, N 2
Examples thereof include organic polar solvents such as -methyl-2-pyrrolidone, dimethylformamide, dimethylsulfoxide, and dimethylacetamide, and particularly preferred is N-methyl-2-pyrrolidone.

【0025】製膜原液の第1成分ポリマーと被抽出成分
である水溶性第2成分との仕込み比は、3:1〜1.
5:1であることが望ましい。第1成分ポリマーが多す
ぎると第2成分の被抽出成分の添加効果が得られずに、
内部に大きな空孔が形成され、安定した多孔質構造が得
られなくなり、第2成分の被抽出成分が多すぎると緻密
な構造となるためである。
The charge ratio of the first component polymer of the stock solution to the water-soluble second component to be extracted is 3: 1 to 1.
Preferably, it is 5: 1. If the amount of the first component polymer is too large, the effect of adding the component to be extracted as the second component is not obtained,
This is because large pores are formed inside and a stable porous structure cannot be obtained, and a dense structure is obtained when the amount of the second component to be extracted is too large.

【0026】水系凝固浴は、60〜80w/w%、望まし
くは65〜75w/w%の上記製膜原液の溶媒を含む水系
凝固浴で、温度が20〜60℃、望ましくは25〜50
℃、時間が0.5〜20分間、望ましくは1〜10分間
の条件で行うことが望ましい。凝固浴を100%非溶媒
で行うと、膜状に広げられた製膜原液がその表面におい
て急速に凝固するため緻密なスキン層と呼ばれる層が形
成されてしまい、当初の目的の多孔質構造が得られな
い。そのため、60〜80w/w%の上記製膜原液の溶媒
を含む水系凝固浴を行うことで、緩慢な凝固が実現し、
表面にも多孔質構造が形成される。凝固浴中の製膜原液
の溶媒の濃度が60w/w%を下回ると上述した製膜原液
の溶媒の添加効果が得られず、80w/w%を越えると凝
固能が不足してしまう。
The aqueous coagulation bath is a water-based coagulation bath containing 60 to 80 w / w%, preferably 65 to 75 w / w% of the solvent of the above-mentioned stock solution, at a temperature of 20 to 60 ° C., preferably 25 to 50 w / w.
It is desirable to perform the reaction at a temperature of 0.5 ° C. for 0.5 to 20 minutes, preferably 1 to 10 minutes. If the coagulation bath is performed with 100% non-solvent, the film-forming stock solution spread in the form of a film rapidly solidifies on its surface, so that a layer called a dense skin layer is formed. I can't get it. Therefore, slow coagulation is realized by performing an aqueous coagulation bath containing 60 to 80 w / w% of the solvent of the film forming stock solution.
A porous structure is also formed on the surface. If the concentration of the solvent of the film forming stock solution in the coagulation bath is less than 60 w / w%, the above-mentioned effect of the addition of the solvent of the film forming stock solution cannot be obtained, and if it exceeds 80 w / w%, the coagulation ability becomes insufficient.

【0027】温度が20℃を下回ると第1成分ポリマー
の析出速度が速すぎて緻密な膜になってしまう。温度が
60℃を上回ると第1成分ポリマーの析出速度が遅すぎ
て膜が形成されない。また、時間が0.5分より短いと
第1成分ポリマーが全て析出しないため膜が形成され
ず、時間が20分より長いと膜構造は変化せず生産効率
が低下してしまう。
When the temperature is lower than 20 ° C., the deposition rate of the first component polymer is too high, resulting in a dense film. If the temperature is higher than 60 ° C., the deposition rate of the first component polymer is too slow to form a film. On the other hand, if the time is shorter than 0.5 minute, the first component polymer is not completely deposited, so that no film is formed. If the time is longer than 20 minutes, the film structure is not changed and the production efficiency is lowered.

【0028】乾燥工程は、特に限定されず、例えば自然
乾燥や電気オーブンなどで、温度が25〜100℃、望
ましくは30〜80℃、時間が1〜24時間、望ましく
は4〜18時間の条件で行う方法などがあげられる。
The drying step is not particularly limited, for example, by natural drying or an electric oven at a temperature of 25 to 100 ° C., preferably 30 to 80 ° C., for a time of 1 to 24 hours, preferably 4 to 18 hours. And the like.

【0029】本発明の異方性の多孔質膜は、検体の供
給、展開を迅速に行うため、親水化剤を含ませる、親水
性を有する材質から構成する、あるいは親水化処理を行
うことが望ましい。親水化剤としては、トライトンX−
100などの界面活性剤、水溶性シリコン、ヒドロキシ
プロピルセルロース、ポリエチレングリコール、ポリプ
ロピレングリコールなどがあげられる。親水化処理とし
ては、プラズマ処理、グロー放電、コロナ放電、紫外線
照射などの処理方法があげられる。
The anisotropic porous membrane of the present invention may contain a hydrophilic agent, be made of a material having hydrophilicity, or be subjected to a hydrophilizing treatment in order to quickly supply and spread the specimen. desirable. As a hydrophilizing agent, Triton X-
Surfactants such as 100, water-soluble silicone, hydroxypropylcellulose, polyethylene glycol, polypropylene glycol and the like. Examples of the hydrophilization treatment include treatment methods such as plasma treatment, glow discharge, corona discharge, and ultraviolet irradiation.

【0030】本発明の異方性の多孔質膜は単独での使用
も可能だが、本多孔質膜の平均孔径の小さい面に、他の
多孔質膜を積層することによって得られる試験紙として
使用することが望ましい。なお、積層方法は特に限定す
ることなく、例えば、単に重ね合わせ周囲を固定する方
法、接着・融着する方法などがあげられる。
Although the anisotropic porous membrane of the present invention can be used alone, it can be used as a test paper obtained by laminating another porous membrane on the surface of the present porous membrane having a small average pore diameter. It is desirable to do. The laminating method is not particularly limited, and examples thereof include a method of simply fixing the periphery of the overlap and a method of bonding and fusing.

【0031】他の多孔質膜としては、検体中の特定成分
と反応して呈色する試薬を担持するものがあげられる。
なお、当該多孔質膜が異方性であるか否かは特に限定さ
れない。上述した検体中の特定成分と反応する試薬とし
ては、グルコースオキシターゼ(GOD)様酵素、ペル
オキシターゼ(POD)様酵素、アスコルビン酸オキシ
ダーゼ様酵素、アルコールオキシダーゼ様酵素、及びコ
レステロールオキシダーゼ様酵素などの酵素剤、及び4
−アミノアンチピリン、N−エチル−N−(2−ヒドロ
キシ−3−スルホプロピル)−m−トルイジンなどの発
色剤があげられ、これらの単数あるいは複数を使用する
ことができる。
As another porous membrane, there can be mentioned a porous membrane which carries a reagent which reacts with a specific component in a sample to give a color.
In addition, whether or not the porous film is anisotropic is not particularly limited. Examples of the reagent that reacts with the specific component in the sample described above include enzyme agents such as glucose oxidase (GOD) -like enzyme, peroxidase (POD) -like enzyme, ascorbate oxidase-like enzyme, alcohol oxidase-like enzyme, and cholesterol oxidase-like enzyme; And 4
Coloring agents such as -aminoantipyrine and N-ethyl-N- (2-hydroxy-3-sulfopropyl) -m-toluidine; one or more of these can be used.

【0032】なお、本発明の試験紙は、検体中の特定成
分の測定装置に脱着可能なチップ、あるいは測定装置自
体に挿入して使用させるものである。測定装置とは、血
液中の糖分、コレステロールや中性脂肪などや、尿中の
糖分、蛋白や潜血などを、定量的あるいは定性的に測定
する装置があげられる。
The test paper of the present invention is used by inserting it into a chip that can be attached to and detached from a measuring device for a specific component in a sample, or a measuring device itself. Examples of the measuring device include a device for quantitatively or qualitatively measuring blood sugar, cholesterol, neutral fat, and the like, and urine sugar, protein, occult blood, and the like.

【0033】[0033]

【実施例】以下、本発明の具体的実施例について説明す
る。各実施例及び比較例の多孔質膜を、以下に示す条件
で製膜した。まず、表1に示す製膜原液を基材(ガラス
板)上に50mlシリンジにて線状に供給し、これをギ
ャップ125μmのアプリケーターによりガラス板上に
塗り拡げた。これを、表1に示す溶媒濃度で調製された
N−メチル−2−ピロリドン(NMP)水溶液からなる
凝固浴中に浸漬し、第1成分ポリマーを析出させた。凝
固浴の温度は35℃とした。その後、水浴中で溶剤成
分、水溶性第2成分を抽出除去した後、40℃オーブン
中で乾燥させて試験紙を得た。第1成分ポリマーとして
ポリエーテルスルホン(スミカエクセル7300P、住
友化学(株)製)を、第2成分としてポリビニルピロリド
ン(BASFポビドンK−90、BASF製)を、溶媒
としてN−メチル−2−ピロリドン(BASF製)を用
いた。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, specific embodiments of the present invention will be described. The porous membranes of the respective examples and comparative examples were formed under the following conditions. First, a film-forming stock solution shown in Table 1 was linearly supplied onto a substrate (glass plate) with a 50 ml syringe, and this was spread on a glass plate with an applicator having a gap of 125 μm. This was immersed in a coagulation bath composed of an aqueous solution of N-methyl-2-pyrrolidone (NMP) prepared at the solvent concentration shown in Table 1 to precipitate the first component polymer. The temperature of the coagulation bath was 35 ° C. Thereafter, the solvent component and the water-soluble second component were extracted and removed in a water bath, and dried in an oven at 40 ° C. to obtain a test paper. Polyether sulfone (Sumika Excel 7300P, manufactured by Sumitomo Chemical Co., Ltd.) as the first component polymer, polyvinylpyrrolidone (BASF povidone K-90, manufactured by BASF) as the second component, and N-methyl-2-pyrrolidone (solvent) as the solvent. BASF).

【0034】表2に製膜された各膜の平均孔径を示す。
各例の膜の平均孔径はASTM F316−86に従い
キャピラリィ フロー ポロメトリィ(Capillary Flow P
orometry)によって測定した。測定装置はパームポロシ
メーター(PMI社製)を使用した。各例の膜の表面平
均孔径は走査型電子顕微鏡(JSM−840日本電子
製)で撮影した画像を画像解析装置(IP−1000P
C 旭化成製)により解析し、視野内の孔の孔径を面積
換算で円相当径として算出し、相加平均を表面平均孔径
とした。したがって、膜の平均孔径と、表面平均孔径は
必ずしも相関関係が成り立つわけではない。膜厚はマイ
クロメーター(ミツトヨ精機製)にて測定した。空孔率
は重量法にて測定した。
Table 2 shows the average pore size of each of the formed films.
The average pore size of the membrane in each case was determined according to ASTM F316-86 by Capillary Flow Porometry.
orometry). The measuring device used was a palm porosimeter (manufactured by PMI). The surface average pore diameter of the film in each example was determined by measuring an image taken with a scanning electron microscope (JSM-840, manufactured by JEOL) using an image analyzer (IP-1000P).
C, manufactured by Asahi Kasei Corporation), the hole diameter of the holes in the visual field was calculated as the equivalent circle diameter in terms of area, and the arithmetic mean was taken as the surface average hole diameter. Therefore, a correlation does not always hold between the average pore diameter of the membrane and the average pore diameter of the surface. The film thickness was measured with a micrometer (made by Mitutoyo Seiki). The porosity was measured by a gravimetric method.

【0035】[0035]

【表1】 [Table 1]

【0036】[0036]

【表2】 [Table 2]

【0037】(試験例1)上記の各実施例および比較例
の多孔質膜を用い、次の実験を行った。評価する膜に下
に示すコート試薬をコートした。評価する膜を反射吸光
度が測定できるように分光光度計(UV−2400(P
C)S 島津製作所社製)のサンプルホルダーに固定
し、ヒト血液を孔径の小さい面へマイクロピペット(エ
ッペンドルフ社製)で5μl添加し、反対面の反射吸光
度の時間変化を測定した。1秒間の反射率の変化割合
が、1%を超えた時から、1秒間の反射率の変化割合が
1%を下回ったときまでの時間をΔtとした。結果を表
3に示す。
(Test Example 1) The following experiments were performed using the porous membranes of the above Examples and Comparative Examples. The membrane to be evaluated was coated with the coating reagent shown below. A spectrophotometer (UV-2400 (P
C) S The sample was fixed to a sample holder (manufactured by Shimadzu Corporation), and 5 μl of human blood was added to a surface having a small pore size using a micropipette (manufactured by Eppendorf), and the time change of the reflection absorbance on the opposite surface was measured. The time from when the change rate of the reflectance for one second exceeded 1% to when the change rate of the reflectance for one second fell below 1% was defined as Δt. Table 3 shows the results.

【0038】コート試薬:GOD、PODおよび4−ア
ミノアンチピリン、N−エチル−N−(2−ヒドロキシ
−3−スルホプロピル)−m−トルイジン(TOO
S)、トライトンX−100
Coating reagents: GOD, POD and 4-aminoantipyrine, N-ethyl-N- (2-hydroxy-3-sulfopropyl) -m-toluidine (TOO
S), Triton X-100

【0039】測定条件 時間変化 測光値:反射率 波長:610nm スリット幅:2.0nm タイミングモード:オート 測定時間:90秒 サンプリングピッチ:0.1sec セル数:1 データ数:901Measurement conditions Time change Photometric value: reflectance Wavelength: 610 nm Slit width: 2.0 nm Timing mode: auto Measurement time: 90 seconds Sampling pitch: 0.1 sec Cell number: 1 Data number: 901

【0040】(試験例2)上記の各実施例および比較例
の多孔質膜を用い、次の実験を行った。評価する膜に上
に示すコート試薬をコートした。評価する膜を反射吸光
度が測定できるように分光光度計(UV−2400(P
C)S 島津製作所社製)のサンプルホルダーに固定
し、ヒト血液を入り口側の面へマイクロピペット(エッ
ペンドルフ社製)で5μl添加し、反対面の反射吸光度
の反射吸光スペクトルを測定した。なお、血液の添加は
孔径の小さい面から行った。血漿を添加した場合のスペ
クトルと比較し血色素の影響の有無を判定した。結果を
表3に示す。
(Test Example 2) The following experiments were performed using the porous membranes of the above Examples and Comparative Examples. The membrane to be evaluated was coated with the coating reagent shown above. A spectrophotometer (UV-2400 (P
C) S The sample was fixed to a sample holder (manufactured by Shimadzu Corporation), and 5 μl of human blood was added to the surface on the entrance side with a micropipette (manufactured by Eppendorf), and the reflection absorption spectrum of the reflection absorption of the opposite surface was measured. In addition, blood was added from the side having a small pore diameter. The presence or absence of the effect of hemoglobin was determined by comparing with the spectrum when plasma was added. Table 3 shows the results.

【0041】測定条件 反射吸光スペクトル 測光値:反射率 波長範囲(nm):開始700 終了500 スキャン速度:中速 スリット幅:2.0nm サンプリングピッチ:1.0nmMeasurement conditions Reflection absorption spectrum Photometric value: reflectance Wavelength range (nm): start 700 end 500 Scan speed: medium speed Slit width: 2.0 nm Sampling pitch: 1.0 nm

【0042】[0042]

【表3】 [Table 3]

【0043】[0043]

【発明の効果】本発明の多孔質膜は、検体の展開速度が
速く、展開に要する時間を短くすることができるととも
に、測色に際し、検体中の浮遊物を濾別・除去し、より
高精度の測定を行うことができる。本発明の多孔質膜
は、他の多孔質膜と積層することにより、検体の展開に
要する時間を飛躍的に短縮することができ、かつ非常に
測定精度が高い、検体中の特定成分測定用試験紙を提供
することができる。
According to the porous membrane of the present invention, the developing speed of the specimen is high, the time required for the development can be shortened, and at the time of color measurement, the suspended matter in the specimen is filtered and removed. Accuracy measurements can be made. The porous membrane of the present invention, by laminating with other porous membranes, can dramatically reduce the time required for sample development, and has extremely high measurement accuracy, for measuring specific components in a sample. Test strips can be provided.

【0044】特に、本発明の多孔質膜は、血液中の糖分
を測定する血糖試験紙に有効に用いられることにより、
血液の展開速度が速く、展開に要する時間を短くするこ
とができるとともに、赤血球等の濾別物を十分に濾別・
除去し、赤血球等の血色素の影響を排し、より高精度の
測定を行うことができる。
In particular, the porous membrane of the present invention can be effectively used for a blood glucose test paper for measuring sugar in blood,
The speed of blood development is high, the time required for blood development can be shortened, and sufficient filtration of filtered substances such as red blood cells
It removes and eliminates the influence of hemoglobin such as red blood cells, and can perform more accurate measurement.

【0045】本発明の多孔質膜の製造方法は、検体の展
開速度が速く、展開に要する時間を短くすることができ
るとともに、測色に際し、検体中の浮遊物を濾別・除去
し、より高精度の測定を行うことができる多孔質膜の製
造方法することができる。本発明の製造方法により得ら
れた多孔質膜は、他の多孔質膜と積層することにより、
検体の展開に要する時間を飛躍的に短縮することがで
き、かつ非常に測定精度が高い、検体中の特定成分測定
用試験紙を提供することができる。
According to the method for producing a porous membrane of the present invention, the development speed of a specimen is high, the time required for development can be shortened, and at the time of color measurement, suspended matter in the specimen is filtered and removed. A method for manufacturing a porous film capable of performing highly accurate measurement can be provided. The porous film obtained by the production method of the present invention is laminated with another porous film,
It is possible to provide a test strip for measuring a specific component in a sample, which can drastically reduce the time required for developing the sample and has extremely high measurement accuracy.

【0046】特に、本発明の製造方法により得られた多
孔質膜は、血液中の糖分を測定する血糖試験紙に有効に
用いられることにより、血液の展開速度が速く、展開に
要する時間を短くすることができるとともに、赤血球等
の濾別物を十分に濾別・除去し、赤血球等の血色素の影
響を排し、より高精度の測定を行うことができる。
In particular, since the porous membrane obtained by the production method of the present invention is effectively used for a blood glucose test paper for measuring the sugar content in blood, the development speed of blood is high and the time required for development is short. In addition to this, it is possible to sufficiently filter out and remove filtered substances such as red blood cells, to eliminate the influence of hemoglobin such as red blood cells, and to perform more accurate measurement.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 2G042 AA01 BD06 BD12 BD16 CA10 CB03 DA08 FA11 FB07 FC03 GA04 HA08 2G045 AA01 AA13 BA01 BA11 BB06 CA26 4F074 AA37 AA64 CB31 DA44 4J002 BJ001 CN032 GD05  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 2G042 AA01 BD06 BD12 BD16 CA10 CB03 DA08 FA11 FB07 FC03 GA04 HA08 2G045 AA01 AA13 BA01 BA11 BB06 CA26 4F074 AA37 AA64 CB31 DA44 4J002 BJ001 CN032 GD05

Claims (13)

【特許請求の範囲】[Claims] 【請求項1】平均孔径が0.1〜2μm、膜厚が50〜
200μm及び空孔率が50〜95%の多孔質膜であ
り、一方の表面の平均孔径と他方の表面の平均孔径の比
が1.5以上である異方性の多孔質膜。
An average pore size of 0.1 to 2 μm and a film thickness of 50 to 50.
An anisotropic porous membrane having a thickness of 200 μm and a porosity of 50 to 95%, wherein the ratio of the average pore diameter on one surface to the average pore diameter on the other surface is 1.5 or more.
【請求項2】膜成分となる非水溶性第1成分ポリマーと
被抽出成分である水溶性第2成分を含み、第1成分ポリ
マーの濃度が12〜15wt%の製膜原液を湿式製膜す
ることによって得られる異方性の多孔質膜。
2. A film-forming stock solution containing a water-insoluble first component polymer serving as a membrane component and a water-soluble second component serving as a component to be extracted, wherein the concentration of the first component polymer is 12 to 15% by weight. An anisotropic porous membrane obtained by this.
【請求項3】平均孔径が0.1〜2μm、膜厚が50〜
200μm及び空孔率が50〜95%の多孔質膜であ
り、一方の表面の平均孔径と他方の表面の平均孔径の比
が1.5以上である請求項2に記載の異方性の多孔質
膜。
3. An average pore diameter of 0.1 to 2 μm and a film thickness of 50 to 50 μm.
The anisotropic porous film according to claim 2, wherein the porous film is 200 µm and has a porosity of 50 to 95%, and the ratio of the average pore size on one surface to the average pore size on the other surface is 1.5 or more. Membrane.
【請求項4】前記製膜原液の前記第1成分ポリマーと前
記第2成分との仕込み比が3:1〜1.5:1である請
求項2乃至3に記載の異方性の多孔質膜。
4. The anisotropic porous material according to claim 2, wherein the charge ratio of the first component polymer to the second component of the stock solution is from 3: 1 to 1.5: 1. film.
【請求項5】60〜80w/w%の前記製膜原液の溶媒を
含む水系凝固浴を行い湿式製膜することによって得られ
る請求項2乃至4に記載の異方性の多孔質膜。
5. The anisotropic porous film according to claim 2, which is obtained by performing a wet film formation by performing an aqueous coagulation bath containing a solvent of the film forming stock solution at 60 to 80 w / w%.
【請求項6】前記第1成分ポリマーがポリエーテルスル
ホンである請求項2乃至5に記載の異方性の多孔質膜。
6. The anisotropic porous membrane according to claim 2, wherein said first component polymer is polyether sulfone.
【請求項7】前記第2成分がポリビニルピロリドンであ
る請求項2乃至5に記載の異方性の多孔質膜。
7. The anisotropic porous membrane according to claim 2, wherein said second component is polyvinylpyrrolidone.
【請求項8】請求項1乃至7に記載の多孔質膜の平均孔
径の小さい面に、他の多孔質膜を積層することによって
得られる試験紙。
8. A test paper obtained by laminating another porous membrane on the surface of the porous membrane according to claim 1 having a small average pore diameter.
【請求項9】膜成分となる非水溶性第1成分ポリマーと
被抽出成分である水溶性第2成分を含み、第1成分ポリ
マーの濃度が12〜15wt%の製膜原液を用いて湿式
製膜することを特徴とする異方性の多孔質膜の製造方
法。
9. A wet process comprising a film-forming stock solution containing a water-insoluble first component polymer as a membrane component and a water-soluble second component as a component to be extracted, wherein the concentration of the first component polymer is 12 to 15 wt%. A method for producing an anisotropic porous membrane, which comprises forming a membrane.
【請求項10】前記第1成分ポリマーと前記第2成分と
の仕込み比が3:1〜1.5:1の製膜原液を用いるこ
とを特徴とする請求項9に記載の異方性の多孔質膜の製
造方法。
10. The anisotropic film according to claim 9, wherein the stock ratio of the first component polymer to the second component is 3: 1 to 1.5: 1. A method for producing a porous membrane.
【請求項11】60〜80w/w%の前記製膜原液の溶媒
を含む水系凝固浴を行い湿式製膜することを特徴とする
請求項9乃至10に記載の異方性の多孔質膜の製造方
法。
11. The anisotropic porous membrane according to claim 9, wherein an aqueous coagulation bath containing 60 to 80% w / w of the solvent for the stock solution is used to perform wet membrane formation. Production method.
【請求項12】前記第1成分ポリマーがポリエーテルス
ルホンであることを特徴とするを特徴とする請求項9乃
至11に記載の異方性の多孔質膜の製造方法。
12. The method for producing an anisotropic porous membrane according to claim 9, wherein said first component polymer is polyether sulfone.
【請求項13】前記第2成分がポリビニルピロリドンで
あることを特徴とする請求項9乃至11に記載の異方性
の多孔質膜の製造方法。
13. The method for producing an anisotropic porous film according to claim 9, wherein said second component is polyvinylpyrrolidone.
JP35231799A 1999-12-10 1999-12-10 Porous membrane and production thereof Pending JP2001164030A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP35231799A JP2001164030A (en) 1999-12-10 1999-12-10 Porous membrane and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35231799A JP2001164030A (en) 1999-12-10 1999-12-10 Porous membrane and production thereof

Publications (1)

Publication Number Publication Date
JP2001164030A true JP2001164030A (en) 2001-06-19

Family

ID=18423245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP35231799A Pending JP2001164030A (en) 1999-12-10 1999-12-10 Porous membrane and production thereof

Country Status (1)

Country Link
JP (1) JP2001164030A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004086037A1 (en) * 2003-03-27 2004-10-07 Terumo Kabushiki Kaisha Test paper and porous membrane
CN100422741C (en) * 2003-03-27 2008-10-01 泰尔茂株式会社 Test paper and porous membrane
JP2013203814A (en) * 2012-03-27 2013-10-07 Terumo Corp Method for producing porous film

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004086037A1 (en) * 2003-03-27 2004-10-07 Terumo Kabushiki Kaisha Test paper and porous membrane
CN100422741C (en) * 2003-03-27 2008-10-01 泰尔茂株式会社 Test paper and porous membrane
US8034301B2 (en) 2003-03-27 2011-10-11 Terumo Kabushiki Kaisha Test paper and porous membrane
US8187457B2 (en) 2003-03-27 2012-05-29 Terumo Kabushiki Kaisha Test paper and porous membrane
JP2013203814A (en) * 2012-03-27 2013-10-07 Terumo Corp Method for producing porous film

Similar Documents

Publication Publication Date Title
US5658444A (en) Electrochemical sensors
JP3220486B2 (en) Visible test strip for blood glucose concentration
KR100356896B1 (en) Large pore synthetic polymer membrane
EP0345781B1 (en) Defined volume test device
CN1143132C (en) Blood sugar detecting strip available for perusal
JP4461205B2 (en) Method for preparing an asymmetric hydrophilic monolithic sulfone polymer membrane
US4824639A (en) Test device and a method for the detection of a component of a liquid sample
JPH026541A (en) Production of porous film, film thus produced and use thereof as support matrix in test piece
US8034301B2 (en) Test paper and porous membrane
AU633210B2 (en) Asymmetric sandwich membrane system as diagnostic test device
US5215712A (en) Apparatus for determination of ion concentration, specific gravity, or osmotic pressure of solution
JP2001164030A (en) Porous membrane and production thereof
JP2001165930A (en) Test paper
JP2001164029A (en) Porous membrane and production thereof
JP5912742B2 (en) Method for producing porous membrane
JP4493535B2 (en) Test paper
KR102079783B1 (en) Strips for measuring materials from bodies
CN100422741C (en) Test paper and porous membrane
JP6304819B2 (en) Inspection test paper
JP2013011571A (en) Anisotropic porous membrane
DE2602975A1 (en) Diagnostic test reagent for body fluids - with highly absorbent carrier of inverse-phase polymeric material contg reagent-system
JPH01158350A (en) Dry analytical material
JPH10160725A (en) Filter paper used in acid-containing stage or under acidic condition and test piece formed thereof
JP2002122583A (en) Dry process analysis element and its manufacturing method

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061106

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090818

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091109

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100303